GlassScriptPhysician profile
Hector C Estepan
NPI 1124142369
$3,135.33
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $864 · 2021: $753 · 2022: $345.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $587.06 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $366.93 | 2019-2022 | |
| Abbvie INC. | $334.13 | 2019-2022 | |
| Lilly USA, LLC | $330.56 | 2019-2022 | |
| Pfizer INC. | $282.19 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $234.09 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $213.20 | 2019-2021 | |
| Allergan, INC. | $149.72 | 2020 | |
| Glaxosmithkline, LLC. | $125.25 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $115.30 | 2020 | |
| Amgen INC. | $94.95 | 2019 | |
| Abbott Laboratories | $65.44 | 2021-2022 | |
| Astellas Pharma US INC | $38.01 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $35.29 | 2020-2021 | |
| Amarin Pharma, INC. | $32.87 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $25.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $23.47 | 2021 | |
| Ironwood Pharmaceuticals, INC | $15.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.50 | 2022 | |
| Mylan Specialty L.P. | $13.69 | 2019 | |
| Dexcom, INC. | $12.70 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Estepan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.